Ikena Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
IKNA Nasdaq 8731 https://www.ikenaoncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ikena Oncology Inc

Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum - Apr 10th, 2024 12:00 pm
Ikena Oncology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag - Mar 14th, 2024 11:50 am
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results - Mar 12th, 2024 12:00 pm
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference - Feb 27th, 2024 1:00 pm
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer - Feb 21st, 2024 9:15 pm
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround - Feb 14th, 2024 2:35 pm
Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround - Jan 24th, 2024 2:35 pm
Ikena Oncology to lay off 35% of staff - Jan 19th, 2024 11:25 am
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates - Jan 18th, 2024 9:05 pm
Broker Revenue Forecasts For Ikena Oncology, Inc. (NASDAQ:IKNA) Are Surging Higher - Nov 10th, 2023 10:03 am
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results - Nov 9th, 2023 12:00 pm
Ikena Oncology to Present at Multiple November 2023 Investor Conferences - Nov 7th, 2023 1:00 pm
Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the Stock? - Sep 27th, 2023 1:01 pm
Ikena Oncology to Participate in September 2023 Investor Conferences - Sep 5th, 2023 12:00 pm
Downgrade: Here's How Analysts See Ikena Oncology, Inc. (NASDAQ:IKNA) Performing In The Near Term - Aug 12th, 2023 12:07 pm
Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates - Aug 10th, 2023 1:30 pm
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update - Aug 10th, 2023 12:00 pm
Loss-making Ikena Oncology (NASDAQ:IKNA) sheds a further US$11m, taking total shareholder losses to 22% over 1 year - Aug 8th, 2023 12:24 pm
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction - Aug 7th, 2023 11:00 am
Recent Price Trend in Ikena Oncology, Inc. (IKNA) is Your Friend, Here's Why - Jun 20th, 2023 12:50 pm